yttrium radioisotopes has been researched along with Cancer of Head in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aluicio-Sarduy, E; Arthur, IS; Barnhart, TE; Bates, AM; Bednarz, BP; Brown, RJ; Carlson, PM; Chakravarty, I; Emma, SE; Engle, JW; Grudzinski, JJ; Hernandez, R; Jagodinsky, JC; Jin, WJ; Kerr, C; Kim, K; Le, T; Marsh, IR; Morris, ZS; Nystuen, EJ; Patel, RB; Sriramaneni, RN; Weichert, JP; Zangl, LM | 1 |
| Gleisner, KS; Gustafsson, J; Nilsson, P | 1 |
| Baumann, M; Cordes, N; Eke, I; Förster, C; Freudenberg, R; Heldt, JM; Ingargiola, M; Kotzerke, J; Kunz-Schughart, LA; Pietzsch, HJ; Runge, R; Steinbach, J | 1 |
| Baumann, M; Brockhoff, G; Cordes, N; Freudenberg, R; Heldt, JM; Ingargiola, M; Kotzerke, J; Kunz-Schughart, LA; Runge, R; Steinbach, J | 1 |
| Chen, X; Jia, B; Jin, X; Li, F; Liu, Y; Liu, Z; Wang, F; Zhao, H | 1 |
| Baumann, M; Cordes, N; Dikomey, E; Eke, I; Grénman, R; Heldt, JM; Kasten-Pisula, U; Kriegs, M; Petersen, C; Pietzsch, HJ; Saker, J; Steinbach, J; Zenker, M | 1 |
| Boellaard, R; Boerman, OC; Finn, R; Snow, GB; Stigter-van Walsum, M; van Dongen, GA; van Eerd, JE; Verel, I; Visser, GW; Vosjan, MJ | 1 |
| Boellaard, R; Boerman, OC; Lammertsma, AA; Snow, GB; van Dongen, GA; van Eerd, J; Verel, I; Visser, GW | 1 |
| Borchardt, PE; Freedman, RS; Quadri, SM; Vriesendorp, HM | 2 |
| Hammer, J | 1 |
| Klein, JL; Kopher, KA; Richtsmeier, WJ; Shikani, AH | 1 |
12 other study(ies) available for yttrium radioisotopes and Cancer of Head
| Article | Year |
|---|---|
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Gene Expression Regulation, Neoplastic; Gene Knockout Techniques; Head and Neck Neoplasms; Immune Checkpoint Inhibitors; Interferon Type I; Lymphocytes; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Radiopharmaceuticals; Time Factors; Tumor Protein, Translationally-Controlled 1; Tumor Stem Cell Assay; Up-Regulation; Yttrium Radioisotopes | 2021 |
On the biologically effective dose (BED)-using convolution for calculating the effects of repair: II. Numerical considerations.
Topics: Antibodies, Monoclonal; Brachytherapy; Fourier Analysis; Head and Neck Neoplasms; Humans; Octreotide; Radiotherapy Planning, Computer-Assisted; Relative Biological Effectiveness; Yttrium Radioisotopes | 2013 |
Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cell Count; Cell Line, Tumor; Cell Survival; Cetuximab; Combined Modality Therapy; DNA Breaks, Double-Stranded; ErbB Receptors; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Intracellular Space; Molecular Targeted Therapy; Pentetic Acid; Phosphorylation; Protein Transport; Signal Transduction; Yttrium Radioisotopes | 2014 |
Potential of a Cetuximab-based radioimmunotherapy combined with external irradiation manifests in a 3-D cell assay.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Survival; Cetuximab; Dose-Response Relationship, Radiation; Drug Carriers; ErbB Receptors; Head and Neck Neoplasms; Humans; Ligands; Monte Carlo Method; Probability; Radiation Tolerance; Radioimmunotherapy; Radionuclide Imaging; Radiotherapy; Spheroids, Cellular; Tumor Cells, Cultured; X-Rays; Yttrium Radioisotopes | 2014 |
Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Cell Line, Tumor; ErbB Receptors; Fluorescent Antibody Technique; Gamma Cameras; Head and Neck Neoplasms; Humans; Mice; Organometallic Compounds; Panitumumab; Radioimmunotherapy; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2010 |
Inactivation of HNSCC cells by 90Y-labeled cetuximab strictly depends on the number of induced DNA double-strand breaks.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Cetuximab; DNA Breaks, Double-Stranded; DNA Repair; ErbB Receptors; Head and Neck Neoplasms; Humans; Immunoconjugates; Radiation Tolerance; Radioimmunotherapy; RNA, Small Interfering; Yttrium Radioisotopes | 2013 |
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Glycoproteins; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunoconjugates; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Xenograft Model Antitumor Assays; Yttrium Radioisotopes; Zirconium | 2003 |
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Phantoms, Imaging; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Yttrium Radioisotopes; Zirconium | 2003 |
Intralesional radioimmunotherapy with Yttrium-90-labeled human monoclonal IgM in nude mice bearing human tumor xenografts.
Topics: Animals; Antibodies, Monoclonal; Blood Cell Count; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Immunoconjugates; Immunoglobulin M; Injections, Intralesional; Mice; Mice, Nude; Quality Control; Radioimmunotherapy; Treatment Outcome; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2004 |
[Interstitial radiotherapy].
Topics: Brachytherapy; Breast Neoplasms; Cobalt Radioisotopes; Gold Radioisotopes; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Iridium; Male; Mouth Neoplasms; Pituitary Neoplasms; Prostatic Neoplasms; Radioisotope Teletherapy; Radioisotopes; Tantalum; Urinary Bladder Neoplasms; Yttrium Radioisotopes | 1983 |
Intralesional radiolabeled human monoclonal IgM in human tumor xenografts.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Immunoconjugates; Immunoglobulin M; Indium Radioisotopes; Injections, Intralesional; Mice; Mice, Nude; Neoplasm Transplantation; Quality Control; Radioimmunotherapy; Radionuclide Imaging; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 1997 |
Radiolabeled antibody therapy for squamous cell carcinoma of the head and neck.
Topics: Animals; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Radiation; Female; Ferritins; Head and Neck Neoplasms; Mice; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Yttrium Radioisotopes | 1992 |